94 related articles for article (PubMed ID: 8314138)
1. Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI.
Buist MR; Golding RP; Burger CW; Vermorken JB; Kenemans P; Schutter EM; Baak JP; Heitbrink MA; Falke TH
Gynecol Oncol; 1994 Feb; 52(2):191-8. PubMed ID: 8314138
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of magnetic resonance imaging for the detection of tumor recurrence in patients with carcinoma of the ovaries.
Kainz C; Prayer L; Gitsch G; Stiglbauer R; Kramer J; Reinthaller A; Kölbl H
J Am Coll Surg; 1994 Mar; 178(3):239-44. PubMed ID: 8149015
[TBL] [Abstract][Full Text] [Related]
3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonography, computed tomography and magnetic resonance imaging in the assessment of pelvic pathology.
Balan P
Eur J Radiol; 2006 Apr; 58(1):147-55. PubMed ID: 16289430
[TBL] [Abstract][Full Text] [Related]
5. Value of ultrasound and magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses.
Huber S; Medl M; Baumann L; Czembirek H
Anticancer Res; 2002; 22(4):2501-7. PubMed ID: 12174952
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative staging of patients with primary ovarian carcinoma by CT and MRI].
Zhu Q; Yoshikawa H; Fujita N
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):296-9. PubMed ID: 11776821
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group.
Kurtz AB; Tsimikas JV; Tempany CM; Hamper UM; Arger PH; Bree RL; Wechsler RJ; Francis IR; Kuhlman JE; Siegelman ES; Mitchell DG; Silverman SG; Brown DL; Sheth S; Coleman BG; Ellis JH; Kurman RJ; Caudry DJ; McNeil BJ
Radiology; 1999 Jul; 212(1):19-27. PubMed ID: 10405715
[TBL] [Abstract][Full Text] [Related]
8. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.
Mitchell DG; Snyder B; Coakley F; Reinhold C; Thomas G; Amendola M; Schwartz LH; Woodward P; Pannu H; Hricak H
J Clin Oncol; 2006 Dec; 24(36):5687-94. PubMed ID: 17179104
[TBL] [Abstract][Full Text] [Related]
9. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
[TBL] [Abstract][Full Text] [Related]
10. The validity of magnetic resonance imaging (MRI) in the staging of bladder cancer: comparison with computed tomography (CT) and transurethral ultrasonography (US).
Nishimura K; Hida S; Nishio Y; Ohishi K; Okada Y; Okada K; Yoshida O; Nishimura K; Nishibuchi S
Jpn J Clin Oncol; 1988 Sep; 18(3):217-26. PubMed ID: 3045372
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
12. Correlation of abdominal ultrasound and computed tomography scans with second- or third-look laparotomy in patients with ovarian carcinoma.
Lund B; Jacobsen K; Rasch L; Jensen F; Olesen K; Feldt-Rasmussen K
Gynecol Oncol; 1990 May; 37(2):279-83. PubMed ID: 2188880
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.
Lee SS; Park SH; Kim HJ; Kim SY; Kim MY; Kim DY; Suh DJ; Kim KM; Bae MH; Lee JY; Lee SG; Yu ES
J Hepatol; 2010 Apr; 52(4):579-85. PubMed ID: 20185194
[TBL] [Abstract][Full Text] [Related]
14. CT and MRI findings of type I and type II epithelial ovarian cancer.
Liu D; Zhang L; Indima N; Peng K; Li Q; Hua T; Tang G
Eur J Radiol; 2017 May; 90():225-233. PubMed ID: 28583639
[TBL] [Abstract][Full Text] [Related]
15. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
16. The clinical value of computed tomography and lymphography in detecting lymph node metastases from epithelial ovarian cancer.
La Fianza A; Campani R; Dore R; Babilonti L; Tateo S
Rofo; 1992 Aug; 157(2):162-6. PubMed ID: 1515625
[TBL] [Abstract][Full Text] [Related]
17. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer.
Hata K; Hata T; Manabe A; Sugimura K; Kitao M
Obstet Gynecol; 1992 Dec; 80(6):922-6. PubMed ID: 1448260
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma.
Liu J; Xu Y; Wang J
Eur J Radiol; 2007 Jun; 62(3):328-34. PubMed ID: 17433597
[TBL] [Abstract][Full Text] [Related]
20. The impact of computed tomography and ultrasonography on the management of patients with carcinoma of the ovary.
Gore ME; Cooke JC; Wiltshaw E; Crow JM; Cosgrove DO; Parsons CA
Br J Cancer; 1989 Nov; 60(5):751-4. PubMed ID: 2679852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
